<li>amiodarone<p>hydroxyzine increases toxicity of amiodarone by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>citalopram<p>hydroxyzine increases toxicity of citalopram by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>clozapine<p>hydroxyzine increases toxicity of clozapine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>droperidol<p>hydroxyzine increases toxicity of droperidol by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>eluxadoline<p>hydroxyzine, eluxadoline.
Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Avoid coadministration with other drugs that cause constipation. Increases risk for constipation related serious adverse reactions.</p></li><li>fluoxetine<p>hydroxyzine increases toxicity of fluoxetine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>iloperidone<p>hydroxyzine increases toxicity of iloperidone by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>isocarboxazid<p>isocarboxazid increases effects of hydroxyzine by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Isocarboxazid should not be administered in combination with antihistamines because of potential additive CNS depressant effects.  MAO inhibitors also prolong and intensify anticholinergic effects of antihistamines. .</p></li><li>procainamide<p>hydroxyzine increases toxicity of procainamide by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>quetiapine<p>hydroxyzine increases toxicity of quetiapine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>quinidine<p>hydroxyzine increases toxicity of quinidine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>sodium oxybate<p>hydroxyzine, sodium oxybate.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Additive CNS depression.</p></li><li>sotalol<p>hydroxyzine increases toxicity of sotalol by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li><li>tranylcypromine<p>tranylcypromine increases effects of hydroxyzine by Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tranylcypromine should not be administered in combination with antihistamines because of potential additive CNS depressant effects. MAO inhibitors also prolong and intensify anticholinergic effects of antihistamines.</p></li><li>ziprasidone<p>hydroxyzine increases toxicity of ziprasidone by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.</p></li>